SCHEMBL30281156

SCHEMBL30281156

Cn1nc(C(=O)O)c(C2CC(F)(F)C2)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30281179 0.86 — —
SCHEMBL28976609 0.84 TEAD1 (0.36) —
SCHEMBL30281268 0.75 SMN1; SMN2 (0.36) —
SCHEMBL29252887 0.71 KDM1A (0.34) —
SCHEMBL2186183 0.70 ALDH1A1 (0.35) —
SCHEMBL30281113 0.62 NPC1 (0.35) —
SCHEMBL25431739 0.62 TRPV4 (0.31) —
SCHEMBL1018048 0.62 HSD11B1 (0.43) —
SCHEMBL24215686 0.62 HCAR2 (0.37) —
SCHEMBL22207600 0.61 MAPT (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4143195-A1 IMIDAZOPYRIDAZINES AS MODULATORS OF IL-17 Janssen Pharmaceutica NV (BE) 2023-03-08 — — EP disclosed
Send feedback